Aparna Hegde
University of Alabama at Birmingham
8 Papers
8 Citations
Aparna Hegde is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger,David S. Ettinger,Douglas E. Wood,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Wallace Akerley,Jessica Bauman,Jessica Bauman,Ankit Bharat,Ankit Bharat,Debora S. Bruno,Debora S. Bruno,Joe Y. Chang,Joe Y. Chang,Lucian R. Chirieac,Thomas A. D'Amico,Thomas J. Dilling,Thomas J. Dilling,Jonathan E. Dowell,Scott N. Gettinger,Matthew A. Gubens,Aparna Hegde,Mark Hennon,Mark Hennon,Rudy P. Lackner,Michael Lanuti,Michael Lanuti,Ticiana A. Leal,Ticiana A. Leal,Jules Lin,Jules Lin,Billy W. Loo,Christine M. Lovly,Christine M. Lovly,Renato Martins,Renato Martins,Erminia Massarelli,Erminia Massarelli,Daniel Morgensztern,Daniel Morgensztern,Thomas Ng,Thomas Ng,Gregory A. Otterson,Gregory A. Otterson,Sandip P. Patel,Sandip P. Patel,Gregory J. Riely,Gregory J. Riely,Steven E. Schild,Steven E. Schild,Theresa A. Shapiro,Theresa A. Shapiro,Aditi P. Singh,Aditi P. Singh,James P. Stevenson,James P. Stevenson,Alda Tam,Alda Tam,Jane Yanagawa,Jane Yanagawa,Stephen C. Yang,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +64 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC as mentioned in this paper.
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Aakash Desai,Justin F. Gainor,Aparna Hegde,Alison M. Schram,Giuseppe Curigliano,Sumanta K. Pal,Stephen V. Liu,Balazs Halmos,Roman Groisberg,Enrique Grande,Tomislav Dragovich,Marc R. Matrana,Neeraj Agarwal,Sant P. Chawla,Shumei Kato,Gilberto Morgan,Pashtoon Murtaza Kasi,Benjamin Solomon,Herbert H. Loong,Haeseong Park,Toni K. Choueiri,Ishwaria Mohan Subbiah,Naveen Pemmaraju,Vivek Subbiah +23 more
TL;DR: In this paper, the authors provide operational COVID-19 vaccine guidance for patients participating in oncology clinical trials, including those involved in trials, which should not affect trial eligibility.
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Aakash Desai,Justin F. Gainor,Aparna Hegde,Alison M. Schram,Giuseppe Curigliano,Sumanta K. Pal,Stephen V. Liu,Balazs Halmos,Roman Groisberg,Enrique Grande,Tomislav Dragovich,Marc R. Matrana,Neeraj Agarwal,Sant P. Chawla,Shumei Kato,Gilberto Morgan,Pashtoon Murtaza Kasi,Benjamin Solomon,Herbert H. Loong,Haeseong Park,Toni K. Choueiri,Ishwaria Mohan Subbiah,Naveen Pemmaraju,Vivek Subbiah +23 more
Nonoperative Treatment of Large (5-7 cm), Node-Negative Non-Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines.
Craig S Schneider,Robert A Oster,Aparna Hegde,Michael C. Dobelbower,John M. Stahl,Adam J. Kole +5 more
TL;DR: In this article, the authors identified factors that predict non-compliance to NCCN guidelines and proposed concurrent chemoradiotherapy (chemoRT) as a treatment option for non-operable lung cancer patients.
5